AIM ImmunoTech (AIM) Accumulated Expenses (2010 - 2026)
AIM ImmunoTech (AIM) reported Accumulated Expenses of $586,000 for Q2 2026, up 2.3% from $573,000 a year earlier but down 12.7% from the prior quarter.
Powered by 
Analysis
AIM ImmunoTech (AIM) Accumulated Expenses (2010 - 2026) Analysis & Trends
At the end of FY2025, AIM ImmunoTech posted Accumulated Expenses of $795,000, up 31.2% from FY2024.
- Accumulated Expenses has a five-year compound annual growth rate of 12.5% (FY2020 to FY2025).
- By year, Accumulated Expenses came in at $606,000 in FY2024 (-69.5%), $1.99 million in FY2023 (+146.4%), $806,000 in FY2022 (+84.0%) and $438,000 in FY2021 (-0.9%).
- Five-year quarterly Accumulated Expenses spans a low of $328,000 in Q1 2022 and a high of $1.99 million in Q4 2023.
- Year over year, Accumulated Expenses has now increased in each of the last three quarters, with an average decline of 23.7% over the last eight quarters.
- The high point for year-over-year Accumulated Expenses in five years was Q3 2022 (growth of 388.1%); the low point was Q4 2024 (a decline of 69.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $671,000 (Q1 2026), $795,000 (Q4 2025) and $679,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | AIM ImmunoTech | 3.08 Mn | -18.22 Mn | 21,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 586,000.00 |
| Mar 31, 2026 | 671,000.00 |
| Dec 31, 2025 | 795,000.00 |
| Sep 30, 2025 | 679,000.00 |
| Jun 30, 2025 | 573,000.00 |
| Mar 31, 2025 | 639,000.00 |
| Dec 31, 2024 | 606,000.00 |
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 799,000.00 |
| Mar 31, 2024 | 1.45 Mn |
| Dec 31, 2023 | 1.99 Mn |
| Sep 30, 2023 | 1.72 Mn |
| Jun 30, 2023 | 528,000.00 |
| Mar 31, 2023 | 696,000.00 |
| Dec 31, 2022 | 806,000.00 |
| Sep 30, 2022 | 1.77 Mn |
| Jun 30, 2022 | 502,000.00 |
| Mar 31, 2022 | 328,000.00 |
| Dec 31, 2021 | 438,000.00 |
| Sep 30, 2021 | 362,000.00 |
API Access
AIM ImmunoTech Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=AIM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "AIM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=AIM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();